Morphologic Stomach Findings in Rats and Mice Treated with the H2 Receptor Antagonists, ICI 125,211 and ICI 162,846
Open Access
- 1 February 1988
- journal article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 16 (2) , 299-304
- https://doi.org/10.1177/019262338801600223
Abstract
The gross and histopathologic findings seen in the stomachs of rats and mice treated with 2 different H2 receptor antagonists are presented. Studies with the first drug, ICI 125,211, elicited dysplasia/carcinoma lesions in 17 of 828 treated rats with 12 of the 17 lesions occurring in the pyloric region of the stomach. No tumors occurred in mice on study for 18 months. Studies conducted with another drug candidate, ICI 162,846, produced neuroendocrine carcinomas in the stomach of rats and mice. Twenty-five rats out of 312 treated male and female rats had neuroendocrine carcinomas in the gastric fundus with a higher tumor incidence in females. In a 24-month mouse study with ICI 162,846, 45 of 300 treated mice developed neuroendocrine carcinomas in the gastric fundus with a higher incidence in males.Keywords
This publication has 6 references indexed in Scilit:
- Changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade.Gut, 1986
- Plasma gastrin and gastric enterochromaffinlike cell activation and proliferationGastroenterology, 1986
- Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.Gut, 1985
- Inhibition of acid and gastric carcinoids.Gut, 1985
- Precancerous conditions and epithelial dysplasia in the stomach.Journal of Clinical Pathology, 1980
- Early sequential lesions during development of experimental gastric cancer with special reference to dysplasiasZeitschrift für Krebsforschung und Klinische Onkologie, 1979